{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:31:13Z","timestamp":1707525073999},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,3,22]]},"DOI":"10.7759\/cureus.36547","type":"journal-article","created":{"date-parts":[[2023,3,23]],"date-time":"2023-03-23T02:20:13Z","timestamp":1679538013000},"source":"Crossref","is-referenced-by-count":0,"title":["Radiotherapy in Managing Metastatic Hepatocellular Carcinoma With Cardiac Involvement and Pulmonary Tumor Thromboemboli: A Case Report"],"prefix":"10.7759","author":[{"given":"Zeta","family":"Chow","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evans","family":"Amoah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhonglin","family":"Hao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahesh","family":"Kudrimoti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27388","article-title":"Emerging trends in hepatocellular carcinoma incidence and mortality","volume":"61","author":"Njei B","year":"2015","unstructured":"Njei B, Rotman Y, Ditah I, Lim JK. Emerging trends in hepatocellular carcinoma incidence and mortality. Hepatology. 2015, 61:191-9. 10.1002\/hep.27388","journal-title":"Hepatology"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v13.i3.414","article-title":"Clinical features and prognosis of patients with extrahepatic metastases from hepatocellular carcinoma","volume":"13","author":"Uka K","year":"2007","unstructured":"Uka K, Aikata H, Takaki S, et al.. Clinical features and prognosis of patients with extrahepatic metastases from hepatocellular carcinoma. World J Gastroenterol. 2007, 13:414-20. 10.3748\/wjg.v13.i3.414","journal-title":"World J Gastroenterol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.soc.2014.09.011","article-title":"Y90 selective internal radiation therapy","volume":"24","author":"Lee EW","year":"2015","unstructured":"Lee EW, Thakor AS, Tafti BA, Liu DM. Y90 selective internal radiation therapy. Surg Oncol Clin N Am. 2015, 24:167-85. 10.1016\/j.soc.2014.09.011","journal-title":"Surg Oncol Clin N Am"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.2217\/fon-2020-0162","article-title":"IMbrave 050: a phase III trial of atezolizumab plus bevacizumab in high-risk hepatocellular carcinoma after curative resection or ablation","volume":"16","author":"Hack SP","year":"2020","unstructured":"Hack SP, Spahn J, Chen M, et al.. IMbrave 050: a phase III trial of atezolizumab plus bevacizumab in high-risk hepatocellular carcinoma after curative resection or ablation. Future Oncol. 2020, 16:975-89. 10.2217\/fon-2020-0162","journal-title":"Future Oncol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31288","article-title":"Epidemiology of hepatocellular carcinoma","volume":"73","author":"McGlynn KA","year":"2020","unstructured":"McGlynn KA, Petrick JL, El-Serag HB. Epidemiology of hepatocellular carcinoma. Hepatology. 2020, 73:4-13. 10.1002\/hep.31288","journal-title":"Hepatology"},{"key":"ref6","unstructured":"American Cancer Society. Cancer Facts & Figures.. (2022). Accessed. 10\/31\/2022: https:\/\/www.cancer.org\/research\/cancer-facts-statistics\/all-cancer-facts-figures\/cancer-facts-figures-2022.html."},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/bs.acr.2020.10.001","article-title":"Hepatocellular carcinoma (HCC): epidemiology, etiology and molecular classification","volume":"149","author":"Chidambaranathan-Reghupaty S","year":"2020","unstructured":"Chidambaranathan-Reghupaty S, Fisher PB, Sarkar D. Hepatocellular carcinoma (HCC): epidemiology, etiology and molecular classification. Adv Cancer Res. 2020, 149:1-61. 10.1016\/bs.acr.2020.10.001","journal-title":"Adv Cancer Res"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2019.08.025","article-title":"Epidemiology and surveillance for hepatocellular carcinoma: new trends","volume":"72","author":"Singal AG","year":"2020","unstructured":"Singal AG, Lampertico P, Nahon P. Epidemiology and surveillance for hepatocellular carcinoma: new trends. J Hepatol. 2020, 72:250-61. 10.1016\/j.jhep.2019.08.025","journal-title":"J Hepatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1177\/1724600821996372","article-title":"Changes in hepatocellular carcinoma aggressiveness characteristics with an increase in tumor diameter","volume":"36","author":"Carr BI","year":"2021","unstructured":"Carr BI, Guerra V, Donghia R, et al.. Changes in hepatocellular carcinoma aggressiveness characteristics with an increase in tumor diameter. Int J Biol Markers. 2021, 36:54-61. 10.1177\/1724600821996372","journal-title":"Int J Biol Markers"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31819","article-title":"Yttrium-90 radioembolization for the treatment of solitary, unresectable HCC: the LEGACY study","volume":"74","author":"Salem R","year":"2021","unstructured":"Salem R, Johnson GE, Kim E, et al.. Yttrium-90 radioembolization for the treatment of solitary, unresectable HCC: the LEGACY study. Hepatology. 2021, 74:2342-52. 10.1002\/hep.31819","journal-title":"Hepatology"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2016.08.029","article-title":"Y90 radioembolization significantly prolongs time to progression compared with chemoembolization in patients with hepatocellular carcinoma","volume":"151","author":"Salem R","year":"2016","unstructured":"Salem R, Gordon AC, Mouli S, et al.. Y90 radioembolization significantly prolongs time to progression compared with chemoembolization in patients with hepatocellular carcinoma. Gastroenterology. 2016, 151:1155-1163.e2. 10.1053\/j.gastro.2016.08.029","journal-title":"Gastroenterology"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.adro.2015.12.003","article-title":"Comparison of outcomes between SBRT, yttrium-90 radioembolization, transarterial chemoembolization, and radiofrequency ablation as bridge to transplant for hepatocellular carcinoma","volume":"1","author":"Mohamed M","year":"2016","unstructured":"Mohamed M, Katz AW, Tejani MA, et al.. Comparison of outcomes between SBRT, yttrium-90 radioembolization, transarterial chemoembolization, and radiofrequency ablation as bridge to transplant for hepatocellular carcinoma. Adv Radiat Oncol. 2016, 1:35-42. 10.1016\/j.adro.2015.12.003","journal-title":"Adv Radiat Oncol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8010055","article-title":"History and evolution of Yttrium-90 radioembolization for hepatocellular carcinoma","volume":"8","author":"Saini A","year":"2019","unstructured":"Saini A, Wallace A, Alzubaidi S, et al.. History and evolution of Yttrium-90 radioembolization for hepatocellular carcinoma. J Clin Med. 2019, 8:55. 10.3390\/jcm8010055","journal-title":"J Clin Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-010-0948-y","article-title":"Radioembolization and systemic chemotherapy improves response and survival for unresectable colorectal liver metastases","volume":"137","author":"Chua TC","year":"2011","unstructured":"Chua TC, Bester L, Saxena A, Morris DL. Radioembolization and systemic chemotherapy improves response and survival for unresectable colorectal liver metastases. J Cancer Res Clin Oncol. 2011, 137:865-73. 10.1007\/s00432-010-0948-y","journal-title":"J Cancer Res Clin Oncol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1259\/bjr.20150943","article-title":"Yttrium-90 hepatic radioembolization: clinical review and current techniques in interventional radiology and personalized dosimetry","volume":"89","author":"Tong AK","year":"2016","unstructured":"Tong AK, Kao YH, Too CW, Chin KF, Ng DC, Chow PK. Yttrium-90 hepatic radioembolization: clinical review and current techniques in interventional radiology and personalized dosimetry. Br J Radiol. 2016, 89:20150943. 10.1259\/bjr.20150943","journal-title":"Br J Radiol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.18926\/AMO\/61212","article-title":"Solitary cardiac metastasis of hepatocellular carcinoma","volume":"74","author":"Aoki H","year":"2020","unstructured":"Aoki H, Utsumi M, Kimura Y, et al.. Solitary cardiac metastasis of hepatocellular carcinoma. Acta Med Okayama. 2020, 74:525-30. 10.18926\/AMO\/61212","journal-title":"Acta Med Okayama"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.24926","article-title":"Hepatocellular carcinoma with cardiac metastasis presenting as presyncope","volume":"14","author":"Haq MS","year":"2022","unstructured":"Haq MS, Fatima T, Caplan J. Hepatocellular carcinoma with cardiac metastasis presenting as presyncope. Cureus. 2022, 14:e24926. 10.7759\/cureus.24926","journal-title":"Cureus"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.17294\/2330-0698.1878","article-title":"Cardiac metastasis after curative treatment of hepatocellular carcinoma: assessment of risk factors, treatment options, and prognosis","volume":"9","author":"Jain G","year":"2022","unstructured":"Jain G, Otto M, Mohammed Abdul MK, Chadha M, Sahajpal A. Cardiac metastasis after curative treatment of hepatocellular carcinoma: assessment of risk factors, treatment options, and prognosis. J Patient Cent Res Rev. 2022, 9:181-4. 10.17294\/2330-0698.1878","journal-title":"J Patient Cent Res Rev"},{"key":"ref19","article-title":"Hepatocellular carcinoma with intra-atrial tumor growth. A clinicopathologic study of 18 autopsy cases","volume":"108","author":"Kojiro M","year":"1984","unstructured":"Kojiro M, Nakahara H, Sugihara S, Murakami T, Nakashima T, Kawasaki H. Hepatocellular carcinoma with intra-atrial tumor growth. A clinicopathologic study of 18 autopsy cases. Arch Pathol Lab Med. 1984, 108:989-92.","journal-title":"Arch Pathol Lab Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1186\/s12872-019-01290-6","article-title":"Isolated metastasis of hepatocellular carcinoma in the right ventricle","volume":"19","author":"Zhang XT","year":"2019","unstructured":"Zhang XT, Li Y, Ren SH, et al.. Isolated metastasis of hepatocellular carcinoma in the right ventricle. BMC Cardiovasc Disord. 2019, 19:287. 10.1186\/s12872-019-01290-6","journal-title":"BMC Cardiovasc Disord"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/142441-radiotherapy-in-managing-metastatic-hepatocellular-carcinoma-with-cardiac-involvement-and-pulmonary-tumor-thromboemboli-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:57:53Z","timestamp":1707508673000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/142441-radiotherapy-in-managing-metastatic-hepatocellular-carcinoma-with-cardiac-involvement-and-pulmonary-tumor-thromboemboli-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,22]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.36547","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3,22]]}}}